Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechanism Data in Gastrointestinal Stromal Tumors in Natures Signal Transduction and Targeted Therapy
Largest prospective clinical trial to-date in a rare subtype of GIST ROCKVILLE,…
ZTE’s “Signal Reach Program” Wins WSIS 2025 Champion Award
GENEVA, July 10, 2025 /PRNewswire/ -- ZTE Corporation (0763.HK / 000063.SZ), a global…
